Mirae Asset Global Etfs Holdings Ltd. Vor Biopharma Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 19,524 shares of VOR stock, worth $18,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,524Holding current value
$18,743% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VOR
# of Institutions
71Shares Held
48MCall Options Held
1.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA22.7MShares$21.8 Million0.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$6.2 Million0.26% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$6.11 Million2.98% of portfolio
-
Laurion Capital Management LP New York, NY2.53MShares$2.42 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.88 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $36.5M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...